Hepatitis B vaccination coverage rate and immune response among primary health care workers in Sarajevo Canton, Bosnia and Herzegovina | ||
| Microbes and Infectious Diseases | ||
| Article 11, Volume 2, Issue 1, February 2021, Pages 60-67 PDF (727.52 K) | ||
| Document Type: Original Article | ||
| DOI: 10.21608/mid.2020.36483.1038 | ||
| Authors | ||
| Sabina Šegalo* 1; Emina Kiseljaković2; Lejla Berhamović3; Arzija Pašalić4; Sabina Mahmutović Vranić1; Emir Berhamović3; Daniel Maestro5; Anes Jogunčić6; Aleksandra Pašić7 | ||
| 1Department of Medical Microbiology, Parasitology and Virology, Faculty of Medicine, University of Sarajevo, Sarajevo, Bosnia and Herzegovina | ||
| 2Department of Medical Biochemistry, Faculty of Medicine, University of Sarajevo, Sarajevo, Bosnia and Herzegovina | ||
| 3Department for Prosthodontics and Dental Implantology, Faculty of Dentistry with Clinics, University of Sarajevo, Sarajevo, Bosnia and Herzegovina | ||
| 4Department of Sanitary Engineering, Faculty of Health Studies, University of Sarajevo, Sarajevo, Bosnia and Herzegovina | ||
| 5Institute for Public Health Federation Bosnia and Herzegovina Department of Sanitary Engineering, Faculty of Health Studies, University of Sarajevo, Sarajevo, Bosnia and Herzegovina | ||
| 6Department of Physiology, Medical School, Sarajevo School of Science and Technology, Sarajevo, Bosnia and Herzegovina | ||
| 7Department of Clinical Chemistry and Biochemistry, Clinical Center University of Sarajevo, Sarajevo, Bosnia and Herzegovina | ||
| Abstract | ||
| Background: Immunization is a key step in preventing the occupational risk of acquiring hepatitis B infection for healthcare workers (HCWs). Objective: The aim of the study was determination the hepatitis B vaccine (HepB) coverage rate among HCWs and support staff and immune response 10 years after primary vaccination. Methods: A retrospective study was conducted in the Public Institution Health Centre of Sarajevo Canton in Bosnia and Herzegovina. Second-generation vaccines Euvax (Sanofi Pasteur, Thailand/LG Life Sciences Ltd, Korea) and Engerix B (GlaxoSmithKline, Belgium) were applied. A level of ≥ 10 IU/L anti-HBs was set as a cut-off value indicating the presence of protective immunity against new HBV infections and successful vaccination. Results: In total, 1541 (75.80%) were fully vaccinated, out of 1126 (73.07%) were females. The median age of participans was 50.5 ± 9.4 years. Control measurement of the anti-HBs level was performed for 409 (26.54%) HCWs. During the research, 37 booster doses were administered. Of the 23 retested participants, anti-HBs ≥10 IU/L were observed in 19 (82.16%). Three non-reactors subject were revealed. Conclusions: A satisfying HepB coverage rate and a high protective rate against hepatitis B infection among HCWs and support staff was achived. These results indicate the active engagement of the institution in the implementation of preventive measures and the high level of awareness regarding the significance of immunization. Our results demonstrated the effectiveness of booster doses. A low prevalence of non-reactors was revealed. Additional research with a focus on occupational risk factors in dental service is advised. | ||
| Keywords | ||
| hepatitis B virus; hepatitis B vaccine; immune response; health care workers; Bosnia and Herzegovina | ||
|
Statistics Article View: 945 PDF Download: 549 |
||
